A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Subpial Gene Delivery in the Mouse Spinal Cord to Evaluate Gene Expression

950 views

August 7th, 2025

In This Article

Abstract

Source: Tadokoro, T., et al. Subpial Adeno-associated Virus 9 (AAV9) Vector Delivery in Adult Mice. J. Vis. Exp. (2017)

This video demonstrates a subpial injection technique for gene delivery to the spinal cord in mice. The procedure involves exposing the dura mater, puncturing the pia mater, and injecting a recombinant adeno-associated virus (rAAV) carrying a fluorescent protein-expressing gene into the subpial space. Following injection and recovery, the virus facilitates gene expression in spinal cord cells, enabling the study of target gene expression.

Protocol

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board.

1. General Animal and Surgical Preparation

  1. Before starting the surgical procedure, thaw the virus (AAV9-UBI-GFP [UBI: Ubiquitin Promoter, GFP: Green Fluorescent Protein]; 5 µL aliquots). Prepare a 5% dextran (10,000 MW) solution by mixing dextran powder in distilled water. Mix the virus solution with 5% dextran solution 1:1 to a final dextran concentration of 2.5%.
    1. Store the virus solution on ice (4 °C).
  2. Use adult C57BL/6J mice (male and female, 20-30 g). Anesthetize the mice using 5% isoflurane (in O2, 1 L/min) and maintain them at 2-3% inhaled isoflurane (in O2, 1 L/min) by nose cone during surgery, depending on the breathing rate and paw pinch response.
  3. Shave the back of the animals with shaving clippers and clean the skin with 2% chlorhexidine.
  4. In chronic recovery studies, follow a strict sterile technique.
  5. If lumbar subpial injections are to be performed, cut the skin overlaying the Th8-L1 vertebrae with a scalpel and detach the paravertebral muscle from Th10-12 spinal vertebrae using scissors.
    1. Mount the animal into a standard stereotaxic frame using mouse spinal clamps.
    2. Shave both sides of the lamina of the Th10-12 vertebrae using a dental drill (drill bit: 0.9 mm, speed: 20,000 rpm) until cracks appear.
    3. Remove cracked bone fragments with forceps and expose the dorsal surface of the lumbar spinal cord.
    4. Cut open the dura about 1 cm using a 30 G stainless steel needle and forceps.

2. Opening the Pial Membrane and Inserting the Subpial Needle for AAV9 Delivery

  1. Mount the 34 G pia-penetrating needle into the Z-arm of an XYZ manipulator using a glass capillary holder (Figure 1A and B).
    NOTE: To manufacture the pia-penetrating needle, the original beveled tip of the 34G needle is sharpened using a glass capillary beveller with diamond abrasive plate - coarse (5.0 µm to 50 µm tip sizes) and grinding angle of 15 - 20°. The tip of the needle (1 mm length, measured from the tip) is then gently bent to about 90° (Figure 1B, left insert).
  2. Using a surgical dissecting scope, set to 8-10X magnification, penetrate the pia with the pia-penetrating needle by about 1 mm (Figure 1C) using the X-arm.
    1. Keep the angle of the penetrating needle to the tissue surface at 5-10°.
  3. After the pia opening, remove the pia-penetrating needle horizontally from the subpial space (Figure 1D) using the X-arm.
    NOTE: Remember the penetrated site by a landmark, such as a blood vessel.
  4. Load a blunt 36G injection needle with AAV9-UBI-GFP virus using a 50-µL microsyringe connected to the injection needle with PE-10 or PE-20 tubing.
  5. Mount the needle into the Z-arm of a second XYZ manipulator (Figure 1A and B) using a glass capillary holder (Figure 1B, right insert).
    NOTE: To manufacture the subpial AAV9 injection needle, the blunt tip of a 36 G needle is polished using a glass capillary beveler with diamond abrasive plate - coarse (5.0 µm to 50 µm tip sizes) to remove the sharp edges. The tip of the needle (2-3 mm length, measured from the tip) is then gently bent to about 90°. The pia-penetrating and subpial injection needles are inserted into 1-2 cm-long 20G slave stainless steel tubing (10 mm from the end of the needle) and glued with epoxy. The use of 20 G (0.91 mm-diameter) tubing is required for a secure attachment to the glass capillary holder.
  6. By manipulating the X, Y, and Z arms of the second manipulator, position the tip of the AAV9 injection needle into the pia-penetrated site and then advance it about 2-3 mm into the subpial space through the previous pial membrane opening using the X-arm ( Figure 1E and F).
    NOTE: 1) The AAV9-UBI-GFP is prepared according to previously reported protocols, and the final titers are adjusted to 1.2 x 1013 genome copies per mL (gc/mL). 2) There is no need to mark the site of the pial opening because it is readily identifiable (Figure 1D).
  7. Inject the AAV9-UBI-GFP (1.5, 3, or 5 µL) into the subpial space using a 50 µL microsyringe (see Table 1 for experimental groups).
  8. Remove the injection needle from the subpial space after the AAV9-UBI-GFP injection is complete.
  9. Close the muscle and skin using 4.0 monofilament suture and surgical clips.
    NOTE: There is no need to seal the open vertebra.
  10. Allow the animals to recover on a heating pad.
  11. For pain control, inject Buprenorphine 0.05 mg/kg/sc every 12 h for 2-3 days post-surgery.

Table 1: Experimental Groups. All experiments were performed in adult C57BL/6J mice.

Experimental GroupsSite/level of AAV9 delivery (*)Volume of AAV9 inj, infusion rateSurvival timeTissue analysis
Group A (n = 7)C2 (bilateral)5 µL/5 min14 daysBrain + spinal cord
Group B (n = 12)L1-L2 (bilateral)1.5 µL or 3µL, 60 sec/µL14 daysBrain + spinal cord
Group C (n = 6)C2 + L1-L2 (bilateral at each level)5 µL/5 min14 daysSpinal cord
* - bilateral = two subpial injections, one delivered into the right and one to the left subpial space of the injected segment(s) are performed.

Access restricted. Please log in or start a trial to view this content.

Results

Subpial injection technique with pia-penetrating and injection needles, surgical procedure steps.

Figure 1: Experimental Setup to Perform Spinal Subpial Injections in an Adult Mouse

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
C57BL/6J MiceJackson Labs664
Lab Standard Stereotaxic for MiceHarvard Apparatus72-9568
Mouse Spinal AdaptorHarvard Apparatus72-4811
XYZ ManipulatorStoelting51604
Manual Infusion PumpStoelting51218
34G Beveled Nanofill NeedleWorld Precision InstrumentsNF34BV-2
36G Blunt Nanofill needleWorld Precision InstrumentsNF-36BL-2
Fluriso, IsofluraneMWI Veterinary Supply502017
Chlorhexidine SolutionMWI Veterinary Supply501027
20G Stainless Steel NeedleBecton-Dickinson305175
23G Stainless Steel NeedleBecton-Dickinson305145
30G Stainless Steel NeedleBecton-Dickinson305128
Cotton Tipped ApplicatorMWI Veterinary Supply27426
Glass Capillary BevellerNarishige InternationalSM-25B
Slide Microscope SuperfrostLeica MicrosystemsM80
50μl MicrosyringeHamilton81242
BD Intramedic PE-20 TubingBecton, Dickinson427406
BD Intramedic PE-10 TubingBecton, Dickinson427401
4-0 monofilament sutureVetOneV1D397
Glass Capillary BevellerNarishigePipet Micro Grinder EG-40
5 min Epoxy (Epoxy Clear)Devcon14310
DextranPolysciences, Inc19411
AAV9-UBC-GFPUCSD Viral Vector Core Laboratory

Tags

Subpial InjectionAAV9 Vector DeliverySpinal Cord Gene ExpressionDura Mater ExposurePia Mater PunctureRecombinant Adeno associated VirusFluorescent Protein GeneStereotaxic Frame SurgeryMicro Syringe InjectionSpinal Cord Tissue Access